| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.36 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |